UBS Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-299
| Closed | – | – | 10250 |
|
|
2021
Q4 | $0 | Buy |
+299
| New | – | ﹤0.01% | 9867 |
|
|
2021
Q3 | – | Sell |
-6,033
| Closed | -$21K | – | 9266 |
|
|
2021
Q2 | $21K | Sell |
6,033
-75
| -1% | -$261 | ﹤0.01% | 6213 |
|
|
2021
Q1 | $21K | Buy |
6,108
+5,679
| +1,324% | +$19.5K | ﹤0.01% | 6345 |
|
|
2020
Q4 | $9K | Sell |
429
-4,682
| -92% | -$98.2K | ﹤0.01% | 6567 |
|
|
2020
Q3 | $69K | Sell |
5,111
-1,565
| -23% | -$21.1K | ﹤0.01% | 4586 |
|
|
2020
Q2 | $283K | Sell |
6,676
-1,598
| -19% | -$67.7K | ﹤0.01% | 3771 |
|
|
2020
Q1 | $228K | Sell |
8,274
-8,826
| -52% | -$243K | ﹤0.01% | 3802 |
|
|
2019
Q4 | $555K | Buy |
17,100
+6,915
| +68% | +$224K | ﹤0.01% | 3817 |
|
|
2019
Q3 | $265K | Buy |
10,185
+8,434
| +482% | +$219K | ﹤0.01% | 4161 |
|
|
2019
Q2 | $64K | Buy |
1,751
+1,238
| +241% | +$45.3K | ﹤0.01% | 4860 |
|
|
2019
Q1 | $11K | Sell |
513
-2,354
| -82% | -$50.5K | ﹤0.01% | 5942 |
|
|
2018
Q4 | $40K | Buy |
2,867
+1,236
| +76% | +$17.2K | ﹤0.01% | 5390 |
|
|
2018
Q3 | $32K | Buy |
1,631
+766
| +89% | +$15K | ﹤0.01% | 5590 |
|
|
2018
Q2 | $19K | Buy |
+865
| New | +$19K | ﹤0.01% | 5828 |
|